These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

408 related articles for article (PubMed ID: 16834756)

  • 1. Pharmacological profile of the selective FAAH inhibitor KDS-4103 (URB597).
    Piomelli D; Tarzia G; Duranti A; Tontini A; Mor M; Compton TR; Dasse O; Monaghan EP; Parrott JA; Putman D
    CNS Drug Rev; 2006; 12(1):21-38. PubMed ID: 16834756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The fatty acid amide hydrolase inhibitor URB597 (cyclohexylcarbamic acid 3'-carbamoylbiphenyl-3-yl ester) reduces neuropathic pain after oral administration in mice.
    Russo R; Loverme J; La Rana G; Compton TR; Parrott J; Duranti A; Tontini A; Mor M; Tarzia G; Calignano A; Piomelli D
    J Pharmacol Exp Ther; 2007 Jul; 322(1):236-42. PubMed ID: 17412883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of fatty acid amide hydrolase inhibitor URB597 in a rat model of trauma-induced long-term anxiety.
    Danandeh A; Vozella V; Lim J; Oveisi F; Ramirez GL; Mears D; Wynn G; Piomelli D
    Psychopharmacology (Berl); 2018 Nov; 235(11):3211-3221. PubMed ID: 30251159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The fatty-acid amide hydrolase inhibitor URB597 does not affect triacylglycerol hydrolysis in rat tissues.
    Clapper JR; Duranti A; Tontini A; Mor M; Tarzia G; Piomelli D
    Pharmacol Res; 2006 Nov; 54(5):341-4. PubMed ID: 16935521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antidepressant-like activity of the fatty acid amide hydrolase inhibitor URB597 in a rat model of chronic mild stress.
    Bortolato M; Mangieri RA; Fu J; Kim JH; Arguello O; Duranti A; Tontini A; Mor M; Tarzia G; Piomelli D
    Biol Psychiatry; 2007 Nov; 62(10):1103-10. PubMed ID: 17511970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The endogenous cannabinoid anandamide produces delta-9-tetrahydrocannabinol-like discriminative and neurochemical effects that are enhanced by inhibition of fatty acid amide hydrolase but not by inhibition of anandamide transport.
    Solinas M; Tanda G; Justinova Z; Wertheim CE; Yasar S; Piomelli D; Vadivel SK; Makriyannis A; Goldberg SR
    J Pharmacol Exp Ther; 2007 Apr; 321(1):370-80. PubMed ID: 17210800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the fatty acid amide hydrolase inhibitor cyclohexyl carbamic acid 3'-carbamoyl-biphenyl-3-yl ester (URB597): effects on anandamide and oleoylethanolamide deactivation.
    Fegley D; Gaetani S; Duranti A; Tontini A; Mor M; Tarzia G; Piomelli D
    J Pharmacol Exp Ther; 2005 Apr; 313(1):352-8. PubMed ID: 15579492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The endogenous cannabinoid anandamide has effects on motivation and anxiety that are revealed by fatty acid amide hydrolase (FAAH) inhibition.
    Scherma M; Medalie J; Fratta W; Vadivel SK; Makriyannis A; Piomelli D; Mikics E; Haller J; Yasar S; Tanda G; Goldberg SR
    Neuropharmacology; 2008 Jan; 54(1):129-40. PubMed ID: 17904589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of fatty acid amide hydrolase inhibition in murine models of emotionality.
    Naidu PS; Varvel SA; Ahn K; Cravatt BF; Martin BR; Lichtman AH
    Psychopharmacology (Berl); 2007 May; 192(1):61-70. PubMed ID: 17279376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The FAAH inhibitor URB597 efficiently reduces tyrosine hydroxylase expression through CB₁- and FAAH-independent mechanisms.
    Bosier B; Muccioli GG; Lambert DM
    Br J Pharmacol; 2013 Jun; 169(4):794-807. PubMed ID: 22970888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain permeant and impermeant inhibitors of fatty-acid amide hydrolase suppress the development and maintenance of paclitaxel-induced neuropathic pain without producing tolerance or physical dependence in vivo and synergize with paclitaxel to reduce tumor cell line viability in vitro.
    Slivicki RA; Xu Z; Mali SS; Hohmann AG
    Pharmacol Res; 2019 Apr; 142():267-282. PubMed ID: 30739035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interactions between environmental aversiveness and the anxiolytic effects of enhanced cannabinoid signaling by FAAH inhibition in rats.
    Haller J; Barna I; Barsvari B; Gyimesi Pelczer K; Yasar S; Panlilio LV; Goldberg S
    Psychopharmacology (Berl); 2009 Jul; 204(4):607-16. PubMed ID: 19259645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Actions of the FAAH inhibitor URB597 in neuropathic and inflammatory chronic pain models.
    Jayamanne A; Greenwood R; Mitchell VA; Aslan S; Piomelli D; Vaughan CW
    Br J Pharmacol; 2006 Feb; 147(3):281-8. PubMed ID: 16331291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of opioids via protection of anandamide degradation by fatty acid amide hydrolase.
    Haller VL; Stevens DL; Welch SP
    Eur J Pharmacol; 2008 Dec; 600(1-3):50-8. PubMed ID: 18762181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis.
    Gobbi G; Bambico FR; Mangieri R; Bortolato M; Campolongo P; Solinas M; Cassano T; Morgese MG; Debonnel G; Duranti A; Tontini A; Tarzia G; Mor M; Trezza V; Goldberg SR; Cuomo V; Piomelli D
    Proc Natl Acad Sci U S A; 2005 Dec; 102(51):18620-5. PubMed ID: 16352709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fatty acid amide hydrolase inhibition heightens anandamide signaling without producing reinforcing effects in primates.
    Justinova Z; Mangieri RA; Bortolato M; Chefer SI; Mukhin AG; Clapper JR; King AR; Redhi GH; Yasar S; Piomelli D; Goldberg SR
    Biol Psychiatry; 2008 Dec; 64(11):930-7. PubMed ID: 18814866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of the fatty acid amide hydrolase inhibitor URB597 on pain-stimulated and pain-depressed behavior in rats.
    Kwilasz AJ; Abdullah RA; Poklis JL; Lichtman AH; Negus SS
    Behav Pharmacol; 2014 Apr; 25(2):119-29. PubMed ID: 24583930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of the endocannabinoid-regulating enzyme monoacylglycerol lipase elicits a CB
    Owens RA; Mustafa MA; Ignatowska-Jankowska BM; Damaj MI; Beardsley PM; Wiley JL; Niphakis MJ; Cravatt BF; Lichtman AH
    Neuropharmacology; 2017 Oct; 125():80-86. PubMed ID: 28673548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergy between enzyme inhibitors of fatty acid amide hydrolase and cyclooxygenase in visceral nociception.
    Naidu PS; Booker L; Cravatt BF; Lichtman AH
    J Pharmacol Exp Ther; 2009 Apr; 329(1):48-56. PubMed ID: 19118134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The endocannabinoid system as a target for novel anxiolytic and antidepressant drugs.
    Gaetani S; Dipasquale P; Romano A; Righetti L; Cassano T; Piomelli D; Cuomo V
    Int Rev Neurobiol; 2009; 85():57-72. PubMed ID: 19607961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.